1 Medipol University, Faculty of Medicine, Department of Medical Biology.
2 University of Health Sciences, Istanbul Training and Research Hospital, Hematology Clinic.
3 Gaziantep University, Faculty of Medicine, Department of Hematology.
4 Istanbul University, Istanbul Faculty of Medicine, Department of Medical Biology.
5 Pamukkale University, Faculty of Medicine, Department of Medical Biology.
| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
To the editor
Patients and Methods
1. Clinical Features of the Chronic Myeloid Leukemia in Chronic Phase Patients.
2. Comparison of Frequencies of ERCC2, XRCC1, XRCC4 - Intron 3 and
XRCC4 (-1394) gene Polymorphisms between Patients with Chronic Myeloid
Leukemia and Healthy Controls.
|Table 3. Univariate analysis (Logrank test) of ERCC2, XRCC1, XRCC4 - Intron 3 and XRCC4 (-1394) Gene Polymorphisms in 62 Patients with Chronic Phase -Chronic Myeloid leukemia.|
|Figure 1. Kaplan-Meier Plots on Event-free Survival (EFS) According to XRCC1 genotypes.|